Armistice Capital, LLC, 10% Owner at ReShape Lifesciences Inc. (RSLS), bought 977 shares at $4.50 ($4K) on 2020-11-17, disclosed to the SEC on 2020-11-17.
Open-market purchase of $4k RSLS by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.14 | 790 | $3K | 79.5% |
| 2 | $4.50 | 187 | $842 | 20.5% |
| Total | $4.21 avg | 977 | $4K | 100% |
| Filing → |
| AVTX | BUY | 2021-09-17 | $25.1M | — | Filing → |
| CERC | BUY | 2021-08-06 | $409K | — | Filing → |
| EYEG | SELL | 2021-08-03 | $830K | — | Filing → |